Stem Cell Therapy for Liver Diseases: Current Perspectives
Frontiers in Bioscience-Landmark · 2023
DOI: 10.31083/j.fbl2812359 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, 2023. Verfasst von Jing Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The 960th Hospital of the PLA, 250000 Jinan, Shandong, China. Hauptthemen laut MEDLINE: Regenerative Medicine, Liver Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shandong Medical and Health Science and Technology Project.
Abstract (Originalsprache)
Stem cell therapy offers a promising avenue for advanced liver disease cases as an alternative to liver transplantation. Clinical studies are underway to explore the potential of stem cells from various sources in treating different liver diseases. However, due to the variability among current studies, further validation is needed to ensure the safety and effectiveness of stem cell therapy. To establish a strong foundation for optimal stem cell therapy applications, selection of suitable stem cell sources, standardization of transplantation protocols, and patient criteria are vital. This review comprehensively examines existing literature on stem cell sources, transplantation methods, and patient selection. Additionally, we discuss novel strategies, including stem cell preconditioning, cell-free therapy, genetic modification of stem cells, and the use of liver organoids, addressing the limitations of current stem cell therapies. Nevertheless, these innovative approaches require further validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, The 960th Hospital of the PLA, 250000 Jinan, Shandong, China.
- Liver Research Unit, Medica Sur Clinic & Foundation and Faculty of Medicine, National Autonomous University of Mexico, 14050 Mexico City, Mexico.
- Department of Gastroenterology, General Hospital of Northern Theater Command (formerly General Hospital of Shenyang Military Area), 110840 Shenyang, Liaoning, China.
Förderung
- National Natural Science Foundation of China
- Shandong Medical and Health Science and Technology Project
Zitieren
APA
Wang, J., Li, Q., Li, W., Méndez-Sánchez, N., Liu, X., & Qi, X. (2023). Stem Cell Therapy for Liver Diseases: Current Perspectives. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2812359
Vancouver
Wang J, Li Q, Li W, Méndez-Sánchez N, Liu X, Qi X. Stem Cell Therapy for Liver Diseases: Current Perspectives. Frontiers in Bioscience-Landmark. 2023. doi:10.31083/j.fbl2812359
BibTeX
@article{Wang2023,
author = {Wang, Jing and Li, Qun and Li, Wenbo and Méndez-Sánchez, Nahum and Liu, Xiaofeng and Qi, Xingshun},
title = {Stem Cell Therapy for Liver Diseases: Current Perspectives},
journal = {Frontiers in Bioscience-Landmark},
year = {2023},
doi = {10.31083/j.fbl2812359}
}
EUVIMED